Alinastine

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameAlinastine
Drug Alias NameLamiakastF-91506-RRF-91506
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsSkin DiseasesConjunctivitis, AllergicAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFaes Farma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFaes Farma
Active IndicationsN/A
Inactive IndicationsSkin DiseasesConjunctivitis, AllergicAsthma

Other Information

ATC CodeN/A
Related LinksN/A